Unlike normal liver tissue, human HCC cells tend to overexpress HK-II, and HK-II overexpression becomes more prominent in a hypoxic environment (e.g., advanced infiltrative hypovascular HCC or after sorafenib administration) [14]. The gene discussed is HK2; the disease is hepatocellular carcinoma.